Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
54M
-
Number of holders
-
95
-
Total 13F shares, excl. options
-
36.3M
-
Shares change
-
+1.32M
-
Total reported value, excl. options
-
$177M
-
Value change
-
-$29.8M
-
Put/Call ratio
-
0.08
-
Number of buys
-
54
-
Number of sells
-
-43
-
Price
-
$4.90
Significant Holders of Fulcrum Therapeutics, Inc. - Common Stock, par value $0.001 per share (FULC) as of Q2 2022
128 filings reported holding FULC - Fulcrum Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q2 2022.
Fulcrum Therapeutics, Inc. - Common Stock, par value $0.001 per share (FULC) has 95 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36.3M shares
of 54M outstanding shares and own 67.16% of the company stock.
Largest 10 shareholders include FMR LLC (6.13M shares), TRV GP III, LLC (3.96M shares), RTW INVESTMENTS, LP (3.96M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (3.36M shares), COWEN AND COMPANY, LLC (2.39M shares), TRV GP IV, LLC (2.34M shares), Point72 Asset Management, L.P. (1.99M shares), Logos Global Management LP (1.95M shares), VANGUARD GROUP INC (1.53M shares), and Deep Track Capital, LP (1M shares).
This table shows the top 95 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.